Skip to main content
. 2024 Feb 22;10(1):e003855. doi: 10.1136/rmdopen-2023-003855

Figure 2.

Figure 2

ACR Responders to Week 52. Randomised set. For binary variables, p values were calculated using a logistic regression model with treatment, prior TNFi exposure, and region as stratification factors. ACR: American College of Rheumatology; BKZ: bimekizumab; NRI: non-responder imputation; OC: observed case; Q4W: every 4 weeks; TNFi: tumour necrosis factor inhibitor.